
Med-X
Total Raised
$11.3MInvestors Count
4Deal Terms
2Funding, Valuation & Revenue
15 Fundings
Med-X has raised $11.3M over 15 rounds.
Med-X's latest funding round was a Angel - III for $1.66M on April 4, 2025.
Med-X's valuation in September 2021 was $88.55 - $88.57M.
Med-X's latest post-money valuation is from April 2025.
Sign up for a free demo to see Med-X's valuations in April 2025 and more.
Med-X's 2023 revenue was $1M - $5M. Med-X's most recent revenue is from 2021.
Sign up for a free demo to see revenue data from 2022, 2021 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
4/4/2025 | Angel - III | $1.66M | Dealmaker | 2 | ||
5/16/2023 | Unattributed - XII | $0.12M | Undisclosed Investors | $1M - $5M FY 2023 | 1 | |
11/8/2022 | Unattributed - XI | $0.1M | Undisclosed Investors | 1 | ||
10/28/2021 | Unattributed - X | |||||
9/11/2021 | Angel - II | $88.55 - $88.57M |
Date | 4/4/2025 | 5/16/2023 | 11/8/2022 | 10/28/2021 | 9/11/2021 |
|---|---|---|---|---|---|
Round | Angel - III | Unattributed - XII | Unattributed - XI | Unattributed - X | Angel - II |
Amount | $1.66M | $0.12M | $0.1M | ||
Investors | Dealmaker | Undisclosed Investors | Undisclosed Investors | ||
Valuation | $88.55 - $88.57M | ||||
Revenue | $1M - $5M FY 2023 | ||||
Sources | 2 | 1 | 1 |
Med-X Deal Terms
2 Deal Terms
Med-X's deal structure is available for 2 funding rounds, including their Angel - III from April 04, 2025.
Round | Angel - III | Angel - II |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Angel - III | |||||||||||||||
Angel - II |
Med-X Investors
4 Investors
Med-X has 4 investors. Dealmaker invested in Med-X's Angel - III funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
4/4/2025 | 4/4/2025 | Dealmaker | 1 Angel - III | Equity Crowdfunding | New York | |
Equity Crowdfunding | Illinois | |||||
Private Equity | New York | |||||
Equity Crowdfunding | California |
First funding | 4/4/2025 | |||
|---|---|---|---|---|
Last Funding | 4/4/2025 | |||
Investor | Dealmaker | |||
Rounds | 1 Angel - III | |||
Board Seats | ||||
Type | Equity Crowdfunding | Equity Crowdfunding | Private Equity | Equity Crowdfunding |
Location | New York | Illinois | New York | California |
Med-X Acquisitions
3 Acquisitions
Med-X acquired 3 companies. Their latest acquisition was Custom Bed Bug on May 30, 2019.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
5/30/2019 | Acquired | 1 | ||||
4/22/2019 | ||||||
12/22/2017 | Debt |
Date | 5/30/2019 | 4/22/2019 | 12/22/2017 |
|---|---|---|---|
Investment Stage | Debt | ||
Companies | |||
Valuation | |||
Total Funding | |||
Note | Acquired | ||
Sources | 1 |
Loading...

